Ellen Chiniara

Track

Insider profile

Currently holds a position at Alexion Pharmaceuticals Inc

Performance

Overall performance
1.2
Performance over holding periods
1.2
30 days 90 days 120 days
Average return -20% 8.2% 15.1%
Success rate 48% 68% 82%
Transactions
3 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Executive Vice President, Chief Legal Officer. Corporate Secretary Alexion Pharmaceuticals Inc Nov. 1, 2019 -
Executive Vice President, General Counsel, Corporate Secretary Alexion Pharmaceuticals Inc Jan. 1, 2018 - Nov. 1, 2019
Ellen Chiniara's trades of Kymera Therapeutics Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2025-03-03 2025-03-03
PrS Proposed sale
56,466
284.69
US$1,855,724 		56,466 284.69 US$1,855,724
2025-03-03 2025-03-03
S Sale
54,369 +9.9%
246.22
US$1,755,284 		54,369 +9.9% 246.22 US$1,755,284
2025-03-03 2025-03-03
S Sale
85,058 +27.9%
432.59
US$749,835 		85,058 +27.9% 432.59 US$749,835
2025-01-06 2025-01-06
PrS Proposed sale
3,129
41.59
US$130,135 		3,129 41.59 US$130,135
2025-01-06 2025-01-06
PlS Planned sale
3,129 -5.4%
41.75
US$130,645 		3,129 -5.4% 41.75 US$130,645
2024-01-05 2024-01-04
S Sale
3,295 -8.8%
22.58
US$74,416 		3,295 -8.8% 22.58 US$74,416
2024-01-04 2024-01-04
PrS Proposed sale
3,295
22.90
US$75,456 		3,295 22.90 US$75,456